Sherman Hom, PhD - CannMed 2024 - Innovation & Investment Summit

Sherman Hom, PhD
Director, Regulatory Affairs
Medicinal Genomics
SPEAKER
REGULATORY PANEL
SAFETY

Cannabis Product Recalls, All States Compendium, Allows Identification of Gaps in Safety Surveillance Regulations

The purpose of this study is to create an ongoing compendium of cannabis product recalls by state and perform analyses within and among states to make general observations, identify historic trends, and identify gaps to enhance consumer awareness and safety.

Product recalls are one of many tools that are used to protect cannabis patients and consumers. There are many issues that may cause a product recall, such as a test that detects a chemical or microbial contaminant that exceeds the action level.

As of November 2023, 25 US States have legal Adult-use and Medical Cannabis Programs, and 14 States have only legal Medical Cannabis Programs. All State Cannabis Programs have adopted testing regulations, which include tests to determine cannabinoid potency and detect product contamination.

Learning Objectives:

Examine the location, quality, and complete listing of cannabis recalls varies state to state
Review the primary reason that caused a recall was due to a required test failure

Understand further research must be conducted after obtaining additional recalls via Freedom of Information Act requests

BIO

Dr. Sherman Hom is the Director of Regulatory Affairs at Medicinal Genomics Corporation (MGC) that markets genetics-based cannabis tests and breeding technologies. At MGC, Sherman provides recommendations to regulatory officials that are tasked with drafting or modifying cannabis, hemp, and psychedelic mushrooms microbial testing regulations to ensure safe products for patients and consumers. He is a member of the AOAC Cannabis Science Program, ASTM International D37 Cannabis Committee, National Cannabis Laboratory Coalition, and the Colorado Public Health and Environment Cannabis Cannabis Science and Policy Forum. Before MGC, he was at the New Jersey Department of Health, Division of Public Health & Environmental Laboratories (PHEL) for 20 years as a Program Manager of various clinical diagnostic testing units, which included the Cannabis Laboratory Microbial Testing Laboratory. Sherman received his B.A in Biology from the University of California at San Diego, PhD in Microbiology from the University of California at Davis, and was a Postdoctoral Fellow in Molecular Genetics at The John Hopkins University.

View CannMed Resources Below:

Feb. 01, 2023

Updating Cannabis Microbial Testing Regulations with Sherman Hom, PhD

ATTENDANCE IS LIMITED. THE OPPORTUNITIES ARE NOT.

Request an Invitation